Biohaven is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of neurological and neuropsychiatric diseases through innovative scientific advancements. With a focus on harnessing the potential of biotechnology, Biohaven aims to develop groundbreaking therapies that improve the lives of patients worldwide.
Specialties
Neurological Disease Treatments
Neuropsychiatric Innovations
Immunology Therapies
Oncology Drug Development
Cutting-Edge Biotechnological Research
Products & Services
Neurology Treatments
Neuropsychiatry Therapies
Oncology Solutions
Immunology Products
Clinical Development Services
Contact Information
No contact information available
Competitors & Similar Companies(8)
Neurocrine Biosciences
California, • United States
Catalent
New Jersey, • United States
Axovant Gene Therapies
Basel-City, • Switzerland
Roche
Basel-City, • Switzerland
Amgen
California, • United States
Biogen
Massachusetts, • United States
Novartis
Basel-City, • Switzerland
Sanofi
Île-De-France, • France
News & Media
Search Terms:
biohaven
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Biohaven
Where is Biohaven located?
The headquarter of Biohaven is located in New Haven, Connecticut, United States
Competitors of Biohaven are Neurocrine Biosciences, Catalent, Axovant Gene Therapies, Roche, Amgen, Biogen, Novartis, Sanofi.
What does Biohaven do?
Biohaven is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of neurological and neuropsychiatric diseases through innovative scientific advancements. With a focus on harnessing the potential of biotechnology, Biohaven aims to develop groundbreaking therapies that improve the lives of patients worldwide.